2022 Monkeypox Outbreak:
Global Trends

World Health Organization

Produced on 06 October 2022

logo

Key Figures

1 Overview

This report provides a global overview of the monkeypox epidemiological situation as reported to WHO as of October 04 2022. The report focuses on laboratory confirmed cases1 as defined by the WHO’s working case definition published in the Surveillance, case investigation and contact tracing for monkeypox interim guidance. Note that countries may use their own case definitions separate from those outlined in the above document. This report should be considered in the context of other WHO information products associated with the 2022 monkeypox outbreak, and monkeypox in general:

  • The biweekly Situation Report provides a comprehensive update of the monkeypox situation and response activities across a variety of domains such as epidemiology, clinical management and communications, replacing the previous Disease Outbreak News format;

  • This global epidemiological report provides in-depth epidemiological information about the monkeypox situation, based primarily on case report forms provided by Member States to WHO under Article 6 of the International Health Regulations (IHR 2005).

Links to these products can be see in more detail at the end of the report.

Since 1 January 2022, cases of monkeypox have been reported to WHO from 107 Member States across all 6 WHO regions. As of October 04 2022 at 17h CEST, a total of 68,998 laboratory confirmed cases and 3,203 probable cases, including 26 deaths, have been reported to WHO. Since 13 May 2022, a high proportion of these cases have been reported from countries without previously documented monkeypox transmission. This is the first time that cases and sustained chains of transmission have been reported in countries without direct or immediate epidemiological links to areas of West or Central Africa.

With the exception of countries2 in West and Central Africa, the ongoing outbreak of monkeypox continues to primarily affect men who have sex with men who have reported recent sex with one or multiple partners. At present there is no signal suggesting sustained transmission beyond these networks.

Confirmation of one case of monkeypox, in a country, is considered an outbreak. The unexpected appearance of monkeypox in several regions in the initial absence of epidemiological links to areas in West and Central Africa, suggests that there may have been undetected transmission for some time.

WHO assesses the global risk as Moderate. Regionally, WHO assesses the risk in the European Region and the Region of the Americas as High and as Moderate in the African Region, Eastern Mediterranean Region and the South-East Asia Region. The risk in the Western Pacific Region is assessed as Low-Moderate. The IHR Emergency Committee on the multi-country outbreak of monkeypox held its second meeting on 21 July 2022. Having considered the views of committee members and advisors as well as other factors in line with the International Health Regulations (2005), the WHO Director-General declared this outbreak a public health emergency of international concern and issued temporary recommendations in relation to the outbreak.

 


  1. For the WHO European region, both confirmed and probable cases are included within confirmed case counts and detailed case data.

  2. Throughout this document, any use of the word country should be considered shorthand for a country, area, or territory

  3. All references to Kosovo should be understood to be in the context of the United Nations Security Council resolution 1244 (1999).


2 Global situation update

The number of weekly1 reported new cases globally has decreased by 16.8% in week 39 (26 Sep - 02 Oct) (n = 3,046 cases) compared to week 38 (19 Sep - 25 Sep) (n = 3,662 cases). The majority of cases reported in the past 4 weeks were notified from the Region of the Americas (85.2%) and the European Region (13.1%).

The 10 most affected countries globally are: United States of America (n = 25,672), Brazil (n = 7,869), Spain (n = 7,209), France (n = 3,999), The United Kingdom (n = 3,654), Germany (n = 3,631), Peru (n = 2,587), Colombia (n = 2,042), Mexico (n = 1,627), and Canada (n = 1,400). Together, these countries account for 86.5% of the cases reported globally.

In the past 7 days, 26 countries reported an increase in the weekly number of cases, with the highest increase reported in Nigeria. 38 countries have reported no new cases in the past 21 days.

In the past 7 days, 1 country reported their first case. Countries which reported their first case in the past 7 days are: Viet Nam (03 October).

Global data are data collected by public sources. These data are largely aggregated cases that have been reported from open and official country sources. The below epidemic curve shows the aggregated number of cases by week according to the date of case reporting.

2.1 Epidemic curves

2.1.1 Global (cases)

Epidemic curve shown for cases reported up to 02 Oct 2022 to avoid showing incomplete weeks of data.

2.1.2 Global (deaths)

Epidemic curve shown for deaths reported up to 02 Oct 2022 to avoid showing incomplete weeks of data.

2.1.3 By WHO Region (cases)

Epidemic curve shown for cases reported up to 02 Oct 2022 to avoid showing incomplete weeks of data. Note different y-axis scales.

2.1.4 By WHO Region (deaths)

Epidemic curve shown for deaths reported up to 02 Oct 2022 to avoid showing incomplete weeks of data. Note different y-axis scales.

2.1.5 Top 10 countries (cases)

Epidemic curve shown for cases reported up to 02 Oct 2022 to avoid showing incomplete weeks of data. Note different y-axis scales.

2.1.6 Epidemic curve by country

Epidemic curve shown for cases reported up to 03 Oct 2022 to avoid showing incomplete weeks of data. In general, trends should be interpretted with caution, as the majority of countries do not report cases on a daily basis.

2.2 Maps

Note: Maps can be clicked to view on a larger scale

2.2.1 Cumulative cases

2.2.2 Weekly cases

2.2.3 Weekly change in cases

2.3 Tables

2.3.1 Cumulative Cases and deaths by WHO Region

Total Monkeypox cases, by WHO region
From 1 Jan 2022. Data as of 04 Oct 2022
Total Confirmed Cases Total Probable Cases Total Deaths Cases in past week1 7-day % change in cases1
Region of the Americas 43,181 3,203 6 2,543 −23%
European Region 24,820 0 5 341 −5%
African Region 726 0 13 147 100%
Western Pacific Region 184 0 0 2 −75%
Eastern Mediterranean Region 64 0 1 11 450%
South-East Asia Region 23 0 1 2 100%
Total 68,998 3,203 26 3,046 −17%
1 Using most recently complete international standard week (Monday - Sunday)


2.3.2 Cumulative cases and deaths by country

Total Monkeypox cases, by WHO region
From 1 Jan 2022. Data as of 04 Oct 2022
Total Confirmed Cases Total Probable Cases Total Deaths
Region of the Americas
United States of America 25,672 0 2
Brazil 7,869 549 2
Peru 2,587 0 0
Colombia 2,042 0 0
Mexico 1,627 2,547 0
Canada 1,400 90 0
Chile 915 11 0
Argentina 396 0 0
Bolivia (Plurinational State of) 200 0 0
Puerto Rico 186 0 0
Ecuador 142 1 1
Dominican Republic 31 1 0
Guatemala 30 4 0
Panama 16 0 0
Jamaica 14 0 0
El Salvador 9 0 0
Uruguay 8 0 0
Honduras 6 0 0
Venezuela (Bolivarian Republic of) 5 0 0
Costa Rica 5 0 0
Cuba 4 0 1
Aruba 3 0 0
Curaçao 3 0 0
Bahamas 2 0 0
Guyana 2 0 0
Paraguay 2 0 0
Barbados 1 0 0
Martinique 1 0 0
Bermuda 1 0 0
Saint Martin 1 0 0
Guadeloupe 1 0 0
European Region
Spain 7,209 0 3
France 3,999 0 0
The United Kingdom 3,654 0 0
Germany 3,631 0 0
Netherlands 1,219 0 0
Portugal 926 0 0
Italy 851 0 0
Belgium 775 0 1
Switzerland 516 0 0
Austria 314 0 0
Israel 254 0 0
Sweden 198 0 0
Ireland 195 0 0
Poland 195 0 0
Denmark 187 0 0
Norway 92 0 0
Greece 82 0 0
Hungary 78 0 0
Czechia 68 0 1
Luxembourg 55 0 0
Slovenia 47 0 0
Finland 40 0 0
Romania 40 0 0
Serbia 40 0 0
Malta 33 0 0
Croatia 29 0 0
Iceland 14 0 0
Slovakia 14 0 0
Estonia 11 0 0
Bulgaria 6 0 0
Gibraltar 6 0 0
Bosnia and Herzegovina 5 0 0
Cyprus 5 0 0
Latvia 5 0 0
Lithuania 5 0 0
Andorra 4 0 0
Ukraine 4 0 0
Monaco 3 0 0
Georgia 2 0 0
Greenland 2 0 0
Montenegro 2 0 0
Republic of Moldova 2 0 0
Russian Federation 2 0 0
Türkiye 1 0 0
African Region
Nigeria 400 0 7
Democratic Republic of the Congo 190 0 0
Ghana 103 0 4
Central African Republic 9 0 0
Cameroon 8 0 2
Congo 5 0 0
South Africa 5 0 0
Benin 3 0 0
Liberia 3 0 0
Western Pacific Region
Australia 136 0 0
Singapore 19 0 0
New Zealand 9 0 0
Japan 6 0 0
China1 5 0 0
Philippines 4 0 0
Republic of Korea 2 0 0
New Caledonia 1 0 0
Guam 1 0 0
Viet Nam 1 0 0
Eastern Mediterranean Region
Sudan 17 0 1
United Arab Emirates 16 0 0
Lebanon 11 0 0
Saudi Arabia 8 0 0
Qatar 5 0 0
Morocco 3 0 0
Iran (Islamic Republic of) 1 0 0
Jordan 1 0 0
Bahrain 1 0 0
Egypt 1 0 0
South-East Asia Region
India 12 0 1
Thailand 10 0 0
Indonesia 1 0 0
-
Total 68,998 3,203 26
1 Cases shown include those in mainland China, Hong Kong SAR and Taipei


2.3.3 Weekly changes - African Region

Summary of Monkeypox cases
As of 04 Oct 2022
Total Cases Total cases per 1M inhabitants Cases in past week1 7-day % change in cases1 Days since last report Date of first reported case
African Region
Nigeria 400 2 123 100% 0 02 Jan 2022
Democratic Republic of the Congo 190 2 16 100% 0 13 Jun 2022
Ghana 103 3 7 100% 0 13 Jun 2022
Central African Republic 9 2 1 100% 0 13 Feb 2022
Cameroon 8 0 0 −100% 0 13 Jun 2022
Congo 5 1 0 0% 0 21 May 2022
South Africa 5 0 0 0% 0 23 Jun 2022
Benin 3 0 0 0% 0 15 Jun 2022
Liberia 3 1 0 0% 0 01 Aug 2022
1 Using most recently complete international standard week (Monday - Sunday)


2.3.4 Weekly changes - Region of the Americas

Summary of Monkeypox cases
As of 04 Oct 2022
Total Cases Total cases per 1M inhabitants Cases in past week1 7-day % change in cases1 Days since last report Date of first reported case
Region of the Americas
United States of America 25,672 78 1032 −29% 0 03 Jun 2022
Brazil 7,869 37 451 −26% 2 10 Jun 2022
Peru 2,587 78 210 −18% 0 28 Jun 2022
Colombia 2,042 40 389 −1% 6 25 Jun 2022
Mexico 1,627 13 260 −18% 6 03 Jun 2022
Canada 1,400 37 7 −73% 0 03 Jun 2022
Chile 915 48 38 −67% 0 18 Jun 2022
Argentina 396 9 70 15% 4 03 Jun 2022
Bolivia (Plurinational State of) 200 17 31 −11% 0 03 Aug 2022
Puerto Rico 186 65 9 −31% 0 01 Jul 2022
Ecuador 142 8 27 8% 0 14 Jun 2022
Dominican Republic 31 3 0 0% 18 06 Jul 2022
Guatemala 30 2 9 50% 0 04 Aug 2022
Panama 16 4 3 200% 3 06 Jul 2022
Jamaica 14 5 0 −100% 10 08 Jul 2022
El Salvador 9 1 3 50% 1 01 Sep 2022
Uruguay 8 2 2 100% 6 31 Jul 2022
Honduras 6 1 0 −100% 12 14 Aug 2022
Costa Rica 5 1 0 0% 0 21 Jul 2022
Venezuela (Bolivarian Republic of) 5 0 0 0% 16 14 Jun 2022
Cuba 4 0 1 100% 0 23 Aug 2022
Aruba 3 28 0 0% 21 21 Aug 2022
Curaçao 3 18 0 −100% 12 18 Aug 2022
Bahamas 2 5 0 0% 45 27 Jun 2022
Guyana 2 2 0 0% 35 24 Aug 2022
Paraguay 2 0 1 100% 4 26 Aug 2022
Barbados 1 4 0 0% 77 19 Jul 2022
Bermuda 1 16 0 0% 73 23 Jul 2022
Guadeloupe 1 2 0 0% 60 05 Aug 2022
Martinique 1 3 0 0% 76 20 Jul 2022
Saint Martin 1 26 0 0% 61 04 Aug 2022
1 Using most recently complete international standard week (Monday - Sunday)


2.3.5 Weekly changes - Eastern Mediterranean Region

Summary of Monkeypox cases
As of 04 Oct 2022
Total Cases Total cases per 1M inhabitants Cases in past week1 7-day % change in cases1 Days since last report Date of first reported case
Eastern Mediterranean Region
Sudan 17 0 10 900% 3 01 Aug 2022
United Arab Emirates 16 2 0 0% 72 24 May 2022
Lebanon 11 2 0 0% 25 20 Jun 2022
Saudi Arabia 8 0 0 0% 35 14 Jul 2022
Qatar 5 2 0 −100% 14 21 Jul 2022
Morocco 3 0 0 0% 36 02 Jun 2022
Bahrain 1 1 0 0% 18 16 Sep 2022
Egypt 1 0 1 100% 7 27 Sep 2022
Iran (Islamic Republic of) 1 0 0 0% 47 18 Aug 2022
Jordan 1 0 0 0% 26 08 Sep 2022
1 Using most recently complete international standard week (Monday - Sunday)


2.3.6 Weekly changes - Table - European Region

Summary of Monkeypox cases
As of 04 Oct 2022
Total Cases Total cases per 1M inhabitants Cases in past week1 7-day % change in cases1 Days since last report Date of first reported case
European Region
Spain 7,209 152 105 −23% 0 18 May 2022
France 3,999 62 56 24% 0 19 May 2022
The United Kingdom 3,654 54 50 52% 0 07 May 2022
Germany 3,631 44 28 −32% 0 20 May 2022
Netherlands 1,219 70 2 −83% 0 22 May 2022
Portugal 926 90 9 0% 0 17 May 2022
Italy 851 14 8 −43% 0 19 May 2022
Belgium 775 67 13 0% 0 19 May 2022
Switzerland 516 60 10 100% 0 21 May 2022
Austria 314 35 6 0% 0 23 May 2022
Israel 254 29 0 −100% 0 21 May 2022
Sweden 198 19 9 29% 0 18 May 2022
Ireland 195 39 5 0% 0 16 May 2022
Poland 195 5 15 150% 0 13 Jun 2022
Denmark 187 32 2 100% 0 23 May 2022
Norway 92 17 1 −50% 0 31 May 2022
Greece 82 8 8 170% 0 09 Jun 2022
Hungary 78 8 0 −100% 0 31 May 2022
Czechia 68 6 1 0% 0 24 May 2022
Luxembourg 55 88 0 0% 0 16 Jun 2022
Slovenia 47 22 1 100% 0 24 May 2022
Finland 40 7 7 100% 0 20 May 2022
Romania 40 2 1 −50% 0 14 Jun 2022
Serbia 40 6 0 −100% 0 17 Jun 2022
Malta 33 64 0 0% 0 30 May 2022
Croatia 29 7 0 −100% 0 24 Jun 2022
Iceland 14 38 2 100% 0 09 Jun 2022
Slovakia 14 3 0 0% 0 07 Jul 2022
Estonia 11 8 0 0% 0 28 Jun 2022
Bulgaria 6 1 0 0% 0 23 Jun 2022
Gibraltar 6 178 0 0% 0 02 Jun 2022
Bosnia and Herzegovina 5 2 2 100% 0 14 Jul 2022
Cyprus 5 6 0 0% 0 03 Aug 2022
Latvia 5 3 0 0% 0 03 Jun 2022
Lithuania 5 2 0 0% 0 04 Aug 2022
Andorra 4 52 0 0% 0 25 Jul 2022
Ukraine 4 0 0 −100% 0 15 Sep 2022
Monaco 3 76 0 0% 0 12 Aug 2022
Georgia 2 0 0 0% 0 15 Jun 2022
Greenland 2 35 0 0% 0 10 Aug 2022
Montenegro 2 3 0 0% 0 31 Jul 2022
Republic of Moldova 2 0 0 0% 0 09 Aug 2022
Russian Federation 2 0 0 0% 0 12 Jul 2022
Türkiye 1 0 0 0% 0 30 Jun 2022
1 Using most recently complete international standard week (Monday - Sunday)


2.3.7 Weekly changes - South-East Asia Region

Summary of Monkeypox cases
As of 04 Oct 2022
Total Cases Total cases per 1M inhabitants Cases in past week1 7-day % change in cases1 Days since last report Date of first reported case
South-East Asia Region
India 12 0 0 0% 2 14 Jul 2022
Thailand 10 0 2 100% 2 21 Jul 2022
Indonesia 1 0 0 0% 2 22 Aug 2022
1 Using most recently complete international standard week (Monday - Sunday)


2.3.8 Weekly changes - Western Pacific Region

Summary of Monkeypox cases
As of 04 Oct 2022
Total Cases Total cases per 1M inhabitants Cases in past week1 7-day % change in cases1 Days since last report Date of first reported case
Western Pacific Region
Australia 136 5 1 −67% 7 20 May 2022
Singapore 19 3 0 0% 19 21 Jun 2022
New Zealand 9 2 0 −100% 12 11 Jul 2022
Japan 6 0 1 0% 5 25 Jul 2022
China2 5 0 0 0% 18 24 Jun 2022
Philippines 4 0 0 0% 43 29 Jul 2022
Republic of Korea 2 0 0 0% 31 22 Jun 2022
Guam 1 6 0 0% 22 12 Sep 2022
New Caledonia 1 4 0 0% 84 12 Jul 2022
Viet Nam 1 0 0 0% 1 03 Oct 2022
1 Using most recently complete international standard week (Monday - Sunday)
2 Cases shown include those in mainland China, Hong Kong SAR and Taipei


2.3.9 Countries with last case reported 21 or more days ago

Days since last reported case
As of 04 Oct 2022
Last Reported Case Days Elapsed
African Region
Benin 15 Jun 2022 111
South Africa 29 Aug 2022 36
Liberia 12 Sep 2022 22
European Region
Türkiye 30 Jun 2022 96
Andorra 5 Aug 2022 60
Greenland 10 Aug 2022 55
Gibraltar 11 Aug 2022 54
Lithuania 11 Aug 2022 54
Monaco 12 Aug 2022 53
Georgia 17 Aug 2022 48
Republic of Moldova 17 Aug 2022 48
Montenegro 22 Aug 2022 43
Cyprus 29 Aug 2022 36
Slovakia 4 Sep 2022 30
Malta 6 Sep 2022 28
Russian Federation 11 Sep 2022 23
Bulgaria 13 Sep 2022 21
Estonia 13 Sep 2022 21
Luxembourg 13 Sep 2022 21
Western Pacific Region
New Caledonia 12 Jul 2022 84
Philippines 22 Aug 2022 43
Republic of Korea 3 Sep 2022 31
Guam 12 Sep 2022 22
Region of the Americas
Barbados 19 Jul 2022 77
Martinique 20 Jul 2022 76
Bermuda 23 Jul 2022 73
Saint Martin 4 Aug 2022 61
Guadeloupe 5 Aug 2022 60
Bahamas 20 Aug 2022 45
Guyana 30 Aug 2022 35
Aruba 13 Sep 2022 21
Eastern Mediterranean Region
United Arab Emirates 24 Jul 2022 72
Iran (Islamic Republic of) 18 Aug 2022 47
Morocco 29 Aug 2022 36
Saudi Arabia 30 Aug 2022 35
Jordan 8 Sep 2022 26
Lebanon 9 Sep 2022 25
South-East Asia Region
Indonesia 22 Aug 2022 43


 



  1. Weekly reported cases, and weekly cases shown in the epidemic curve are aggregated according to international standard weeks, running from Monday to Sunday.

3 Detailed case data

Detailed case data are acquired via direct reporting of case based data via WHO Member States. Data from cases are reported1 according to the WHO minimum dataset under the International Health Regulations (IHR 2005) Article 6, and subsequently aggreagated and presented below. Note that completeness of records is variable, meaning denominators for each output may be different from one another. All of the following is derived from the detailed case data, and as a result, overall numbers may not be reflective of figures shown with aggregate case numbers. All detailed cases shown are confirmed cases, where the reporting date occured after 01 January 2022.


  1. Note that a small number of detailed case reports are constructed from official public reports about individual cases.

3.1 Reporting coverage

The detailed case dataset was last updated on October 05 2022. As of this date, the total number of detailed confirmed cases reported is 63,523, representing 92.9% of all aggregated cases reported.

The table below indicate the reporting coverage between reported aggregated confirmed cases and detailed confirmed cases by countries and per region.

Note that for all tables below, in order to best align modes of reporting, total confirmed cases are shown as of:

  1. The most recent Friday (30 September) for data in the Region of the Americas.

  2. The most recent Tuesday (04 October) for data in the European Region.

Total cases shown fully as of 04 October are shown in the global trends section.

3.1.1 Table - Coverage by region

Monkeypox reporting completeness
As of 04 Oct 20221
Total Confirmed Cases Total Detailed Confirmed Cases2 % Detailed Cases reported
Region of the Americas 42,560 38,595 90.7%
European Region 24,820 24,677 99.4%
African Region 726 174 24.0%
Western Pacific Region 184 24 13.0%
Eastern Mediterranean Region 64 42 65.6%
South-East Asia Region 23 11 47.8%
1 Total confirmed cases shown as of date of last detailed case report for the WHO Region of the Americas and WHO European Region.
2 Note that in rare cases total detailed cases may exceed total confirmed cases due to ongoing data cleaning issues




3.3 Case profile (overall)

As shown below, and stated previously, the ongoing outbreak is largely developing in men who have sex with men (defined as homosexual or bisexual males in detailed case forms) networks. In the following analyses, we have re-coded men reported as bisexual as men who have sex with men. Note that reported sexual orientation does not necessarily reflect who the case has had recent sexual history with nor does it imply sexual activity. Generally, severity has been low, with few reported hospitalisations and deaths:

Key features of these cases are as follows:

  • 97.5% (36664/37617) of cases with available data are male, the median age is 35 years (IQR: 29 - 42).

  • Males between 18-44 years old continue to be disproportionately affected by this outbreak as they account for 79.1% of cases.

  • Of all cases with available data, 2.5% (953/37617) are female:

    • The majority of of these cases are reported from the Region of the Americas (502/953; 53%) and the European Region (381/953; 40%)

    • Of the cases where sexual orientation is reported, the majority are Heterosexual (295/341; 87%).

    • The most commonly reported exposure setting is in a household (78/189; 41%), and the most common form of transmission is via sexual encounters (137/262; 52%)

  • Of the 38,343 cases where age was available, there were 331 (0.9%) cases reported aged 0-17, out of which 93 (0.2%) were aged 0-4:

    • The majority of cases aged 0-17 are reported from the Region of the Americas (191 /331; 58%).

    • Of the cases aged 0-17, 17 have reported exposure in a school setting.

  • 20 were reported to be pregnant or recently pregnant. Of these:

    • 4, 4, and 7 cases were in their first, second, and third trimesters respectively. 4 were in an unknown trimester, and 4 were six weeks or less post partum.

    • The median age was 28 (IQR: 24.25 - 30).

    • 2 of these cases were known to be hospitalised. 0 were known to be admitted to ICU, and hospitalised. 0 were known to have died.

    • The most common mode of transmission was sexual encounter (2/3 cases where route was known). The most common exposure setting was household (3/4 cases where setting was known).

  • Among cases with known data on sexual orientation, 90.0% (15703/17456) identified as men who have sex with men. Of those identified as men who have sex with men, 511/15703 (3.3%) were identified as bisexual men.

  • Among those with known HIV status 49.1% (9,519/19,369) were HIV-positive. Note that information on HIV status is not available for the majority of cases, and for those for which it is available, it is likely to be skewed towards those reporting positive HIV results.

  • 425 cases were reported to be health workers. However, most were infected in the community and further investigation is ongoing to determine whether the remaining infection was due to occupational exposure.

  • Of all reported types of transmission, a sexual encounter was reported most commonly, with 10,587 of 12,132 (87.3%) of all reported transmission events.

  • Of all settings in which cases were likely exposed, the most common was in party setting with sexual contacts, with 3,151 of 6,386 (49.3%) of all likely exposure categories.

3.3.1 Demographic Information

Note that the proportions shown below should be interpreted with caution. When considering some variables, it is more likely that a yes response will be obtained when compared to a no response after consideration of true proportions of these factors. This is most likely to be true for variables where reported answers can only be yes or no, such as HIV status, health worker status, travel history, hospitalisation, ICU, and death.

Case profiles
As of October 05 2022
Reported values1 Unknown or Missing Value
Yes No
Men who have sex with men 15703 (90.0%) 1753 (10.0%) 46051
HIV-Positive 9516 (49.1%) 9849 (50.9%) 44142
Health worker 425 (3.2%) 12944 (96.8%) 50138
Travel History 1631 (16.9%) 8016 (83.1%) 53860
Sexual Transmission 10583 (87.3%) 1545 (12.7%) 51379
Hospitalised2 2144 (7.3%) 27398 (92.7%) 33965
ICU 19 (0.2%) 10732 (99.8%) 52756
Died 8 (0.0%) 25979 (100.0%) 37520
1 Note given true proportions of variables, yes reporting may be common than no reporting
2 May be hospitalised for isolation or medical treatment




3.3.2 Age-sex pyramid



3.3.3 Age-sex pyramid by region

Note that only regions with 50 or more cases with age and sex information are shown. Note different x-axis scales.



3.3.4 Age-sex pyramid (Hospitalised cases)

Note that some cases represented below may be hospitalised for isolation rather than treatment purposes.



3.3.5 Age-sex pyramid (ICU cases)

Note that some cases represented below may be hospitalised for isolation rather than treatment purposes.



3.3.6 Sexual orientation by region



3.3.7 Transmission type

Transmission data were available for 12,132/63,523 (19.1%) of cases.

When considering transmission, note that separating transmission via skin-to-skin contact during sex and transmission via bodily fluids is not possible. While skin-to-skin contact with lesions remains an important transmission route, monkeypox virus has been isolated from semen samples and rectal swabs from confirmed cases.



3.3.8 Exposure settings

Exposure setting data were available for 6,981/63,523 (11.0%) of cases.

Note that multiple exposure settings can be attributed to a single case. Here, differentiation here between party settings and large events is determined by size of the event, although there is no formal size threshold to distinguish the two.



3.4 Case profile (excluding men who have sex with men)

The following outputs apply to cases that are not men who have sex with men, and sexual orientation is known. Other categories of sexual orientation that are reportable are:

  • Heterosexual
  • Lesbian (women who have sex with women)
  • Other

As stated above, men who have sex with men in this case refers to those who have a reported sexual orientation of men whi have sex with men, and men reported as bisexual. As above, note that reported sexual orientation does not necessarily reflect persons who the case has had recent sexual history with nor does it imply sexual activity. Up until this point in time, the 2022 multi-country Monkeypox outbreak has been overwhelmingly concentrated in networks of men who have sex with men For this reason, understanding events in which individuals of other sexual orientation have acquired monkeypox is important to monitor potential of sustained spillover into the general population.

  • 80.2% (1381/1721) of cases with available data are male; the median age is 33 years (IQR: 27-41).

  • Males between 18-44 years old account for 65.7% of cases.

  • Among those with known HIV status 30.5% (382/1251) were HIV-positive. Note that information on HIV status is not available for the majority of cases, and for those for which it is available, it is likely to be skewed towards those reporting positive HIV results.

  • 60 cases were reported to be health workers. However, most were infected in the community and further investigation is ongoing to determine whether the remaining infection was due to occupational exposure.

  • Of all reported types of transmission, sexual encounter was reported most commonly, with 282 of 437 (64.5%) of all reported transmission events.

  • Of all settings in which cases were likely exposed, the most common was in others, with 92 of 269 (34.2%) of all likely exposure categories.

3.4.1 Demographic Information

Note that the proportions shown below should be interpreted with caution. When considering some variables, it is more likely that a yes response will be obtained when compared to a no response after consideration of true proportions of these factors. This is most likely to be true for variables where reported answers can only be yes or no, such as HIV status, health worker status, travel history, hospitalisation, ICU, and death.

Case profiles (excluding men who have sex with men)
As of October 05 2022
Reported values1 Unknown or Missing Value
Yes No
Men who have sex with men 0 1753 (100.0%) 0
HIV-Positive 382 (30.5%) 869 (69.5%) 502
Health worker 60 (6.3%) 892 (93.7%) 801
Travel History 103 (13.9%) 636 (86.1%) 1014
Sexual Transmission 282 (64.5%) 155 (35.5%) 1316
Hospitalised2 190 (15.8%) 1009 (84.2%) 554
ICU 3 (0.7%) 427 (99.3%) 1323
Died 0 1154 (100.0%) 599
1 Note given true proportions of variables, yes reporting may be common than no reporting
2 May be hospitalised for isolation or medical treatment




3.4.2 Age-sex pyramid



3.4.3 Transmission type

Transmission data were available for 437/1,753 (24.9%) of cases.

When considering transmission, note that separating transmission via skin-to-skin contact during sex and transmission via bodily fluids is not possible. While skin-to-skin contact with lesions remains an important transmission route, monkeypox virus has been isolated from semen samples and rectal swabs from confirmed cases.

3.4.4 Exposure settings

Exposure setting data were available for 288/1,753 (16.4%) of cases that were not men who have sex with men.

Note that multiple exposure settings can be attributed to a single case. Here, differentiation here between party settings and large events is determined by size of the event, although there is no formal size threshold to distinguish the two.

3.5 Symptomatology

Although most cases in current outbreaks have presented with mild disease symptoms, monkeypox virus (MPXV) may cause severe disease in certain population groups (young children, pregnant women, immunosuppressed persons)

Among the cases who reported at least one symptom, the most common symptom is any rash and is reported in **** of cases with at least one reported symptom. Note that identifying true denominators for symptomatology is difficult due to a general lack of negative reporting and symptom definitions that may vary between countries’ reporting systems.

A bar chart and table showing symptoms is shown below. Here any rash refers to one or more rash symptoms (systemic, oral, genital, or unknown location), and any lymphadenopathy refers to either general or local lymphadenopathy.

3.5.1 Bar chart - Symptoms

3.5.2 Table - Symptoms

Summary of symptoms
As of October 05 2022
All Male Female
Any rash 21,469 (83.5%) 20,433 (83.7%) 399 (66.1%)
Fever 14,839 (57.7%) 14,181 (58.1%) 306 (50.7%)
Systemic rash 12,727 (49.5%) 11,766 (48.2%) 327 (54.1%)
Genital rash 11,695 (45.5%) 11,124 (45.5%) 141 (23.3%)
Headache 7,554 (29.4%) 7,068 (28.9%) 244 (40.4%)
Fatigue 7,521 (29.3%) 7,005 (28.7%) 186 (30.8%)
Any lymphadenopathy 7,453 (29.0%) 7,326 (30.0%) 115 (19.0%)
Muscle ache 6,916 (26.9%) 6,472 (26.5%) 211 (34.9%)
General lymphadenopathy 6,235 (24.3%) 6,134 (25.1%) 96 (16.1%)
Local lymphadenopathy 4,779 (18.6%) 4,711 (19.3%) 59 (9.9%)
Rash, unknown location 3,271 (12.7%) 3,250 (13.3%) 19 (3.1%)
Sore throat 3,160 (12.3%) 2,900 (11.9%) 92 (15.2%)
Oral rash 2,502 (9.7%) 2,049 (8.4%) 37 (6.1%)
Chills 1,634 (6.4%) 1,307 (5.4%) 38 (6.3%)
Vomiting 466 (1.8%) 438 (1.8%) 25 (4.1%)
Anogenital pain and/or bleeding 301 (1.2%) 296 (1.2%) 5 (0.8%)
Asymptomatic 20 (0.1%) 20 (0.1%) 0
Other 3 (0.0%) 2 (0.0%) 1 (0.2%)
Conjunctivitis 0 0 0
Cough 0 0 0
Diarrhea 0 0 0
Genital oedema 0 0 0
Lymphadenopathy, location unknown 0 0 0

 


4 In focus: West and Central Africa

Since 1970, human cases of monkeypox have been reported in 9 countries in the WHO African region: Cameroon, Central African Republic, Congo, Côte d’Ivoire, Democratic Republic of the Congo, Gabon, Liberia, Nigeria, and Sierra Leone. The true burden of monkeypox in these countries is not known. This section specifically focuses on those countries in the African region with a history of monkeypox, in order to highlight any differences in epidemiology between those countries and those within the ongoing 2022 monkeypox outbreak without a history of monkeypox. Notably, while the ongoing 2022 monkeypox outbreak has been associated with Clade II of monkeypox virus, historically outbreaks have been driven by that and Clade I.

Historically, the sexual component of transmission in the countries above has been thought to contribute less to human to human transmission of monkeypox than has been observed in the ongoing global outbreak. It should also be noted that there is limited testing capacity for monkeypox in many of these countries, which has led to underascertainment of monkeypox cases.

In 2022, as of 04 Oct 2022, there have been 615 confirmed cases of monkeypox reported in these countries and 9 deaths. These represent 1% and 35% of global cases and deaths respectively. In addition, 174 (28% of all cases) detailed cases have been reported to WHO.

Of those cases with detailed data:

  • 111 male cases (64.5%) and 61 female cases (35.5%) have been reported

  • The median age is 25 (IQR: 11 - 36).

  • Of the 169 cases where age was available, there were 65 (38.5% of total) cases reported aged 0-17, out of which 21 (12.4% of total) were aged 0-4.

  • There are currently no detailed cases for which transmission or exposure setting detail is available

Trends from these countries are shown below:

4.1 Epidemic curve by date of notification (cases)

Epidemic curve shown for cases reported up to 03 Oct 2022 to avoid showing incomplete weeks of data.

4.2 Epidemic curve by date of notification (deaths)

Epidemic curve shown for deaths reported up to 03 Oct 2022 to avoid showing incomplete weeks of data.

4.3 Epidemic curve by date of onset

This epidemic curve is shown for those cases with detailed case data, giving date of onset.

4.4 Age-sex pyramid

 


5 Literature Summary & Epidemic Parameters

In order to promote a better understanding of the dynamics of the current monkeypox outbreak and to support forecasting work, WHO has undertaken an effort to extract epidemiological parameters, such as incubation period and generation interval, from the literature. The initial literature screening is performed and maintained by the Public Health Agency of Canada (PHAC). The overall search strategy is as follows:

  • Inclusion criteria: monkeypox and monkeypox virus
  • Study design:
    • Any study design including primary and secondary studies (both animal and human)
    • Guidelines and commentaries are not excluded but are not searched systematically.
  • Publication language: no restriction for peer-reviewed articles, grey literature is focused on English
  • Publication date: from April 14, 2022
  • Bibliographic databases and other sources searched:
    • PubMed Scopus
    • Pre-print servers: Europe PMC, arXiv and SSRN
    • WHO, PHAC, CDC, ECDC, UKHSA

The tables below provide an overview of the most relevant estimates for incubation period and generation interval extracted from the literature where the following criteria are met:

  • Studies with a sample size greater than 5
  • Clear estimate of the specific parameter

The epidemic parameter tables are updated once per week on Fridays. Please note that some of these sources are still undergoing the peer-review process, therefore readers are advised to exercise care when interpreting findings.

5.1 Parameters

Incubation Period
As of 27 Sep 2022
Reference N Mean1 95% CI1 95% CrI1 SD1 Median1 IQR1 Range1 Distribution
Miura et al. [1] 18 8.5 - 6.6 - 10.9 - - - - Log-normal
Charniga et al. [2] 40 7.6 - 6.2 - 9.7 1.8 6.4 - - Log-normal
Rodríguez et al. [3] 45 - - - - - - - -
Thornhill et al. [4] 23 - - - - 7.0 - 3 - 20 -
Català et al. [5] 77 - - - - 6.0 - 4 - 9 -
Tarín-Vicente et al. [6] 144 - - - - 7.0 5 - 10 1 - 19 -
Guzzetta et al. [7] 30 9.1 6.5 - 10.9 - - - - - Gamma
Mailhe et al. [8] 112 - - - - 6.0 3 - 8 - -
Moschese et al. [9] 16 - - - - 11.0 11 - 16 - -
Gomez-Garberi et al. [10] 14 - - - - 13.0 - 3 - 30 -
O'Laughlin et al. [11] 527 7.0 - - - - 4 - 9 - -
Source: PHAC
1 Units are in days




Generation Interval
As of 27 Sep 2022
Reference N Mean1 95% CrI1 SD1 Distribution
Guzzetta et al. [7] 16 12.5 7.5 - 17.3 - Gamma
Source: PHAC
1 Units are in days


5.2 Bibliography

 


6 Disclaimers

6.1 Data Overview and Visualizations

The WHO 2022 monkeypox global trends report aims to provide frequently updated data visualizations. Caution must be taken when interpreting all data presented, and differences between information products published by WHO, national public health authorities, and other sources using different inclusion criteria and different data cut-off times are to be expected. While steps are taken to ensure accuracy and reliability, all data are subject to continuous verification and change. All counts are subject to variations in case detection, definitions, laboratory testing, and reporting strategies between countries, states and territories.

WHO makes no warranties or representations regarding the contents, appearance, completeness, technical specifications, or accuracy of the report. WHO disclaims all responsibility relating to, and shall not be liable for, any use of the report, the results of such use, or the reliance thereon.

WHO reserves the right to make updates and changes to the report without notice, and accepts no liability for any errors or omissions in this regard.

The user of the report is responsible for the interpretation and use of the analysis and outputs performed by the report. The submission of content to the report does not imply WHO’s approval or endorsement of that content, or that the content is appropriate for any purpose or meets any established standard or requirement

Any designations employed or presentation by the user in its use of the app, including tables and maps, do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers and boundaries.

All references to Kosovo should be understood to be in the context of the United Nations Security Council resolution 1244 (1999).

A dispute exists between the Governments of Argentina and the United Kingdom of Great Britain and Northern Ireland concerning sovereignty over the Falkland Islands (Malvinas).

7 Acknowledgements

We gratefully acknowledge the input of national public health staff involved in surveillance activities and data submission to WHO, the European Centre for Disease Prevention and Control (ECDC) for the provision of surveillance data collected via the TESSy platform, as well as external partners who contributed additional insights and contextual information on the data.